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Abstract
Background: Although the activity of tinnitus-related ion co-transporter are known, their mRNA expressions has
seldom been reported. We aimed to investigate the mRNA expressions of tinnitus-related ion co-transporter genes,
and treatment effects of Spirulina.
Methods: The mRNA expressions of K+–Cl− co-transporter (KCC2) and Na-K-2Cl co-transporter 1 (NKCC1) genes in
the cochlea and brain of mice were evaluated after tinnitus was induced by intraperitoneal injection of salicylate.
The effects of spirulina water extract on these gene expressions were investigated.
Results: Compared to the control group, the tinnitus scores increased significantly, however, the salicylate-induced
tinnitus could be reduced significantly by spirulina water extract. The tinnitus group had higher of borderline
significance mRNA expression of KCC2 gene in the cochlear, significantly higher in the temporal lobes and in the
frontal lobes. Meanwhile, compared to the tinnitus group, the spirulina group had significantly lower mRNA
expression of KCC2 gene in the cochlear, temporal lobes, frontal lobes and parahippocampus/hippocampus.
However, the NKCC1 mRNA expression was not significantly different between three groups in the cochlea and
these brain areas.
Conclusion: Salicylate-induced tinnitus might be associated with increased mRNA expression of KCC2 gene, but
not with mRNA expressions of NKCC1 gene in the cochlear and some tinnitus-related brain areas. Spirulina reduced
the expression of KCC2 genes in salicylate-induced tinnitus.
Keywords: Tinnitus, Salicylate, mRNA, K+– Cl− co-transporter gene, Na-K-Cl co-transporter gene, Spirulina
Abbreviations: CAT, Catalase; COX-2, Cyclooxygenase type 2; CPC, C-phycocyanin; GR, γ-amino butyric acid
receptor; IL-1β, Interleukine-1β; KCC2, K+– Cl− co-transporter; NADPH, Nicotinamide adenine dinucleotide
phosphate; NKCC1, Na-K- 2Cl co-transporter 1; NR, N-methyl D-aspartate receptor; SAMP8, Senescence-accelerated
prone-8; SPL, Sound pressure level; TNF-α, Tumor necrosis factor-α
Background
Subjective tinnitus is most commonly believed to originate
from the cochlear and/or central nervous system dysfunc-
tion at the levels of the brainstem, subcortical and cortical
level, as well as the limbic system [1, 2]. The functions of
certain neurotransmitter receptors, ion channels and/or
co-transporters have been proposed to be associated with
tinnitus, for example, activation of vanilloid receptors in
the inner ear [3], N-methyl D-aspartate receptor (NMDA
receptor, NR) in the inner ear [4], acetylcholine receptors
in the auditory cortex [5], and dopamine receptors in the
auditolimbic dopaminergic pathway exhibited excitatory
effects on tinnitus [6]. On the contrary, activation of can-
nabinoid receptors in the ventral cochlear nucleus [7] and
γ-amino butyric acid receptors (GABA receptor, GR) in
the inferior colliculus (IC) [8] or auditory cortex [9] exhib-
ited inhibitory effects on tinnitus.
Some co-transporter and/or ion channels, for example,
K+– Cl− co-transporter (KCC2) [10, 11], voltage-gated
sodium channels [12, 13], transient outward potassium
currents, the glycine-induced chloride channels [14],
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L-type calcium channels [15], and Na-K-2Cl co-transporter
1 (NKCC1) [16], were reported to be associated with tin-
nitus. Among them, KCC2 is a neuron-specific Cl− trans-
porter whose role in adult central nervous neurons is to
maintain low intracellular Cl− concentrations needed for
the hyperpolarizing responses to the inhibitory amino acid
GABA and glycine of the auditory nucleus [10, 17]. The
NKCC is a class of membrane proteins that transport Na,
K, and Cl ions into and out of a wide variety of epithelial
and non-epithelial cells. The NKCC1 isoform is present in
a wide variety of tissues, whereas, NKCC2 is found only in
the kidney [18]. Inhibition of NKCC1 with its potent antag-
onist bumetanide reduces pain behavior in rats following
spinal cord injury [19].
Tinnitus-related changes in gene expression have also
played an important role in tinnitus. For example, the
mRNA expression of the c-fos gene increased in the
auditory brainstem [20] and cortices [21]. The expres-
sion of NR subtype 2A (NR2A) genes increased in the
auditory cortices of rats in salicylate-induced tinnitus
[21]. The expression levels of NR2B, tumor necrosis
factor-α (TNF-α) and interleukine-1β (IL-1β) genes
increased significantly, whereas cyclooxygenase type 2
(COX-2) gene expression decreased in the cochlea and
IC of mice with salicylate-induced tinnitus [22, 23].
NKCC1 mRNA expression increased in the chronic
tinnitus and the recovery period, but decreased in the
phase of acute tinnitus [16]. However, the mRNA
expression of KCC2 was still unclear in tinnitus. Fur-
thermore, based on recent animal studies in our labora-
tory, neural inflammation and oxidation-reduction status
(redox) may be novel mechanisms in tinnitus [22–24].
Meanwhile, it is well known that inflammation and/or
oxidative stress could violate cell functions not only at
the cell membrane level, but also at the cytoplasm and
nucleus levels. Thus, it is reasonable to expect that anti-
inflammatory and/or anti-oxidative agents might prevent
cell dysfunction in genetic level and beyond.
Spirulina is a microscopic blue-green alga. Spirulina pla-
tensis and its active ingredient, C-phycocyanin (CPC),
exert antioxidative, anti-inflammatory effects via inhibition
of COX-2 [25] and/or nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase enzymes [26]. S. platensis
water extract significantly slowed the loss of memory by
augmenting catalase (CAT) activity in the brain of the sen-
escence- accelerated prone-8 (SAMP8) mouse sub-strain
[27]. CPC and S. platensis water extract reduced salicylate-
induced tinnitus and down-regulated mRNA and protein
expression for NR2B, TNF-α, IL-1β, and COX-2 genes in
the cochlea and IC of SAMP8 mice [24]. It reduced also
salicylate-induced over-expression of the manganese-
superoxide dismutase (Mn-SOD) gene and malondialde-
hyde (MDA) levels, but increased salicylate-induced
down-regulation of the CAT gene in many brain areas
[28]. However, the effects of S. platensis water extract on
the mRNA expression of KCC2 and/or NKCC1 genes after
salicylate-induced tinnitus have not so far been reported.
As we have mentioned above, the functions of KCC2
and NKCC1 were associated with tinnitus. But, the mRNA
expression of these co-transporter genes in salicylate-
induced tinnitus and the effects of S. platensis water
extract on them were still limited or unclear. Therefore,
we aimed to investigate these questions. We hypothesized
that mRNA expression of KCC2 and/or NKCC1 genes
altered after 4-days of salicylate-induced tinnitus in the
cochlea and brain. S. platensis water extract could modu-




Twenty-four 3-month-old male SAMP8 mice were ran-
domly and equally divided into three groups (8 mice in
each group): a control group (saline-treated), tinnitus
group (salicylate-treated), and spirulina group (salicylate
plus S. platensis water extract-treated). All groups were
fed with normal diet. Institutional Animal Care and Use
Committee of Dalin Tzu Chi Hospital approved the
protocol used in this study.
Behavioral conditioning to active avoidance task
All mice were trained to perform an active avoidance
task, which was performed in a conditioning box with
an electrical floor and a climbing pole, according to the
design of Guitton et al. [29] and Hwang et al. [22–24].
The conditioning paradigm consisted of six sessions
performed per day for five days (day 1–5). Each session
lasted 15 to 20 min, as there were 10 trials per session.
Inter-trial intervals lasted at least one minute. For each
trial, the conditioning stimulus was a 50 dB sound pres-
sure level (SPL) pure tone with a frequency of 10 kHz
and of a three-second duration, and the unconditioned
stimulus was a 3.7 mA electric foot-shock presented for
30 s, re. Guitton’s protocol [29], by adjusting the electric
voltage with fixed copper wire resistance on the floor.
The time between the conditioned stimulus and the un-
conditioned stimulus was one second. The mice would
climb up through the pole into a safe area after the
coupled conditioned and unconditioned stimuli. Elec-
trical shocks were stopped by the experimenter when
the animal climbed correctly. The “true-positive” score
was the level of performance assessed by the number of
times the mice climbed correctly in response to sound.
Mice were considered to be conditioned when the
“true-positive” score reached at least 80 % in three
consecutive sessions. Only conditioned mice were placed
in the tinnitus experiments.
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Induction and testing of tinnitus
When conditioned, an active avoidance task of one ses-
sion with 10 trials was performed 2.0 h after intraperito-
neal injections of saline, either alone or containing
300 mg/kg sodium salicylate (Sigma - Aldrich, St. Louis,
MO) for 4 days (day 6 ~ 9). To avoid changes attribut-
able to hearing loss induced by salicylate (about 10 to
20 dB during 4-days injections), the intensity of the
sound that elicited the behavioral responses was adjusted
by increasing the sound intensity to 70 dB SPL for the
salicylate-treated group. By doing so, we could keep the
sound sensation levels of all mice in three groups almost
similar [22–24].
During tinnitus testing, a sound of three-seconds dur-
ation was given first for 3.0 s in each trial, and the mice
were observed for another 5.0 s to check if they would per-
form the task correctly (true-positive). If so (true-positive),
the mice were put down on the floor for ongoing observa-
tion, i.e., if animals stayed on the safe area >10 s. If not,
electrical shock was given by the experimenter to remind
the mice to climb up the pole. Then, the mice were also
placed on the floor for ongoing observation, i.e., if animals
stayed on the safe area >10 s.
Finally, the experimenter observed the total number
(false-positive score or tinnitus score) of times the mice
climbed during the inter-trial silent period of 1.0 min
composed of 10 trials.
Samples isolation and RNA extraction from the cochlea
and brain
The pairs of cochlea, brainstem including the IC,
temporal lobes, frontal lobes, and para-hippocampus/
hippocampus were immediately dissected using a Zeiss
stereomicroscope and stored at −80 °C refrigerator until
used. RNA isolation was performed using the RNA-Bee
isolation reagent (Friendswood, USA) with a tissue
homogenizer according to the manufacturer’s protocol.
The RNA quality was assessed by an Agilent Bioanalyzer
2100, and the ratio of absorbance measurements was con-
ducted at 260 and 280 nm using the nanodrop method.
Reverse transcription-polymerase chain reaction (RT-PCR)
cDNA was synthesized from total RNA by reverse
transcription using MMLV high performance reverse tran-
scriptase (Epicentre Biotechnologies, USA) in a P × 2
Thermal cycler (Thermo Electron Corporation Bioscience
Technologies Division, USA). For each RT reaction, a posi-
tive control was performed with 1.0 μg of total RNA. RT
was carried out at 37 °C for 1 h. For PCR amplification,
3.0 μL cDNA and primers were used according to the
supplier’s instructions with DreamTaq™ DNA polymerase
(Fermentase, USA). The primers were: KCC2-F-5′-CTC
AAC AACCTGACGGACTG-3′, KCC2-R-5′-GCACAA
CACCATTGGTTGCG-3′ for brain tissues [30]; KCC2-F-
5′-ATGTACATCCTTGGCACGAT -3′, KCC2-R-5′-AGG
AAGACC AAGGCAAACTT-3′ for cochlear tissues [31];
NKCC1-F-5′-TGT TGGATTCGC AGAGACTG-3′, NKC
C1-R-5′-GTTCCTTTGGGTATGGCTGA-3′ [32]; β-actin
F-5′-CCACACCCGCCACCAGTTCG-3′, β-actin R-5′-
CCCATTCCC ACCATC ACACC-3′ [33]. The thermal
cycling conditions for PCR were adjusted to the following:
3.0 min initial set-up at 95 °C; followed by 50 cycles, each
of which consisted of 45 s of denaturation at 95 °C, 45 s of
annealing at 56 °C, and 72 s of extension at 72 °C for
KCC2 gene of brain tissues; 45 s of denaturation at 95 °C,
45 s of annealing at 50 °C, and 72 s of extension at 72 °C
for KCC2 gene of cochlear tissues; of 45 s of denaturation
at 95 °C, 45 s of annealing at 52.1 °C, and 72 s of extension
at 72 °C for NKCC1 gene; of 45 s of denaturation at 95 °C,
45 s of annealing at 50 °C, and 72 s of extension at
72 °C for β-actin gene. A final 10 min at 72 °C for
all above genes.
Quantitation of PCR products
The DNA products were measured by the Mini Horizontal
Electrophoresis System (MJ-105/MP-100, Major Science,
Taiwan) and by E-Box-1000/26 M Inspection Certificate &
Analysis Systems (E-Box Spp-010 E-capt soft ware, USA).
The expression levels of KCC2 and NKCC1 genes were
presented as relative ratios in comparison to β-actin gene.
Statistical analysis
The data are presented as the mean ± standard deviation
(SD), unless indicated otherwise. The tinnitus scores
were compared between the three groups by a one-way
ANOVA test. The mRNA expression levels of KCC2,
NKCC1 or β-actin genes at each site were compared also
by one-way ANOVA test. All above analysis were per-
formed by the commercialized software “STATA10”, and
p values <0.05 were considered statistically significant.
Results
Figure 1 display the tinnitus scores before, and 4.0 days
after salicylate injection. The tinnitus score was not
significantly different in three groups before intraperito-
neal salicylate injection (4.3 ± 2.9 versus 3.8 ± 2.9 versus
2.0 ± 1.0, p = 0.3318). But, the tinnitus score was sig-
nificantly different in three groups four days after intra-
peritoneal salicylate injection (7.6 ± 3.8 versus 14.5 ± 4.6
versus 5.4 ± 3.4, p = 0.0005). The tinnitus group had a
higher significant tinnitus score than the control group
(p = 0.006); whereas the spirulina group had significantly
lower tinnitus score than the tinnitus group (p = 0.001).
Figure 2 shows the mRNA expression levels of the
KCC2 gene in the cochlea and several brain areas. The
KCC2 mRNA expression was significantly different
between three groups in the cochlea (one-way ANOVA,
p = 0.0036). The tinnitus group had higher of borderline
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significance mRNA expression of KCC2 gene than the
control group in the cochlea (1.96 ± 0.22 versus 1.72 ± 0.13,
p = 0.066); whereas the spirulina group had significantly
lower mRNA expression of KCC2 gene than the tinnitus
group in the cochlea (1.58 ± 0.12 versus 1.96 ± 0.22,
p = 0.003). Second, the KCC2 mRNA expression was dif-
ferent and of borderline significance between the three
groups in the brainstem (2.34 ± 0.28 versus 2.36 ± 0.43 ver-
sus 1.94 ± 0.30, one-way ANOVA, p = 0.0937). Third, the
KCC2 mRNA expression was significantly different be-
tween the three groups in the temporal lobes (one-way
ANOVA, p = 0.0067). The tinnitus group had significantly
higher mRNA expression of KCC2 gene than the control
group in the temporal lobes (0.82 ± 0.24 versus 0.42 ± 0.19,
p = 0.025), and the spirulina group had significantly lower
mRNA expression of KCC2 gene than the tinnitus group
in the temporal lobes (0.37 ± 0.25 versus 0.82 ± 0.24,
p = 0.010). Fourth, the KCC2 mRNA expression was
significantly different between three groups in the frontal
lobes (one-way ANOVA, p = 0.0008). The tinnitus group
had significantly higher mRNA expression of KCC2 gene
than the control group in the frontal lobes (0.85 ± 0.23
versus 0.46 ± 0.12, p = 0.003), and the spirulina group had
significantly lower mRNA expression of KCC2 gene than
the tinnitus group in the temporal lobes (0.45 ± 0.11 ver-
sus 0.85 ± 0.23, p = 0.002). Fifth, the KCC2 mRNA expres-
sion was significantly different between three groups in
the para-hippocampus/hippocampus (one-way ANOVA,
p = 0.0074). The tinnitus group did not display signifi-
cantly higher mRNA expression of KCC2 gene than the
control group in the hippocampus/parahippocampus
(0.92 ± 0.11 versus 0.66 ± 0.23, p = 0.143), but the spirulina
group had significantly lower mRNA expression of KCC2
gene than the tinnitus group in the parahippocampus/
hippocampus (0.48 ± 0.25 versus 0.92 ± 0.11, p = 0.006).
Figure 3 shows the mRNA expression levels of the
NKCC1 gene in the cochlea and several brain areas. The
NKCC1 mRNA expression was not significantly different
between the three groups of the cochlea (1.70 ± 0.89
versus 1.45 ± 0.60 versus 1.08 ± 0.64, one-way ANOVA,
p = 0.3469), in the brainstem (2.26 ± 0.82 versus 2.66 ± 0.20
versus 2.80 ± 0.80, one-way ANOVA, p = 0.3714), in
the temporal lobes (1.75 ± 0.23 versus 1.78 ± 0.19 ver-
sus 1.94 ± 0.12, one-way ANOVA, p = 0.1991), in the
frontal lobes (0.78 ± 0.20 versus 0.78 ± 0.17 versus
0.68 ± 0.15, one-way ANOVA, p = 0.5237), and in the para-
hippocampus/hippocampus (1.13 ± 0.61 versus 0.87 ± 0.32
versus 0.95 ± 0.30, one-way ANOVA, p = 0.5802).
Discussion
This experimental study showed that mRNA expression
of KCC2 gene increased, whereas NKCC1 gene expression
did not change significantly, in the cochlea and several
tinnitus-related brain areas during salicylate-induced
tinnitus. Combined with previous reports about the
changes of ion channel and/or co-transporter functions
Fig. 1 The tinnitus scores before and after salicylate injection. The
tinnitus score was not significantly different in three groups before
salicylate injection. However, after salicylate injection, the tinnitus
group had higher significantly tinnitus score than the control group,
and the spirulina group had significantly lower tinnitus score than
the tinnitus group
Fig. 2 The mRNA expression levels of the KCC2 gene. The KCC2
expression was significantly different between three groups in the
cochlea, temporal lobes, frontal lobes, and in the hippocampus/
parahippocampus, but of borderline significance in the brainstem
Fig. 3 The mRNA expression levels of the NKCC1 gene. The KCC2
expression was not significantly different between three groups in
all tested areas
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[10, 11, 18, 19], we suggested that a high dose of salicylate
could not only induce tinnitus, but also could modulate
expressions of KCC2 in the genetic level and beyond in
mice. However, our results related to NKCC1 gene expres-
sion were not consistent with findings of Yao et al. [16], in
which the NKCC1 mRNA expression increased in the
chronic tinnitus phase and the recovery period, but de-
creased in the acute tinnitus phase.
Early expression of the KCC2 selectively enhances
GABAergic synapses [34]. Targeted deletion of the
neuronal-specific KCC2 generates mice with a profound
seizure disorder and confirms the central role of this
transporter in modulating neuronal excitability [35],
whereas the KCC2 could promote GABAergic excitation
in the mature rat hippocampus during ictal epileptiform
activity [11]. K-Cl co-transporter KCC3 may be involved
in degenerative peripheral neuropathies [19]. The neur-
onal KCC2 maintains the low intracellular chloride con-
centration required for the fast hyperpolarizing actions
of inhibitory neurotransmitters in the mature central
nervous system (CNS) [10, 17]. We found that salicylate
could increase the mRNA expression of KCC2. However,
the exact mechanisms linking this finding and salicylate-
induced tinnitus remain further studies.
The renal-specific Na-Cl co-transporter (NCC) and
Na-K-2Cl co-transporter (NKCC2) are involved in
Gitelman and Bartter syndrome, respectively, and the
autosomal recessive forms of metabolic alkalosis. NKCC1
is involved in hearing, salivation, pain perception, sperm-
atogenesis, and the control of extracellular fluid volume.
Inhibition of NKCC1 with its potent antagonist bumeta-
nide reduces pain behavior in rats following spinal cord
injury [19]. NKCC1 mRNA expression increased in the
chronic tinnitus and recovery period, but decreased in the
acute tinnitus condition [16]. However, the expressions of
NKCC1 gene were not altered significantly in the cochlea
and several tinnitus-related brain areas investigated in our
study. This discrepancy might be due to the differences in
study design, dose of salicylate, interval between the entry
and the end of study, etc.
The inflammation and/or redox imbalance might
interfere with the neural cell functions via modulation of
ion channels, cotransporters, and/or neurotransmitters.
In addition, inflammation might alter mRNA expression
of cation chloride co-transporters, including KCC2 and
NKCC1, in sensory neurons [36–38]. In acute arthritis,
both NKCC1 and KCC2 mRNA increased in superficial
dorsal horn, and this was accompanied by an increase in
protein expression. In chronic arthritis, NKCC1 expres-
sion remained raised, but KCC2 mRNA and protein ex-
pression returned to control levels [36]. Furthermore,
based on results from recent animal studies in our
laboratory, neural inflammation [22, 23] and oxidative
stress [24] may be novel mechanisms in tinnitus. We
had found that spirulina water extract, with its ant-
inflammatory and anti-oxidative abilities [25, 26], could
reduce salicylate-induced tinnitus and up-regulation of
TNF-alpha, IL-1beta, NR2B, and COX-2 [22, 23]. In this
study, we found that spirulina could reduce the salicylate-
induced up-regulation of KCC2 gene in the cochlea,
temporal lobes, frontal lobes, and para-hippocampus/
hippocampus. Thus, we proposed that spirulina might
modulate the mRNA expression of KCC2 by reducing
neuroinflammation and/or oxidative stress. However, we
indeed could not know clearly if the effect of Spirulina
was to antagonize the effect of salicylate and/or was on
the basal expression of these transporters.
Conclusion
Salicylate-induced tinnitus might be associated with in-
creased mRNA expression of KCC2 gene, but not with
mRNA expression of NKCC1 gene in the cochlea and
tinnitus-related brain areas. This animal study provided
new information that high doses of salicylate could not
only induce tinnitus, but also could modulate expres-
sions of KCC2 and NKCC1 at the genetic level and
beyond in mice. In addition, spirulina water extract
might modulate the mRNA expression of KCC2 possibly
by reducing neuroinflammation and/or oxidative stress.
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